HilleVax, Inc (NASDAQ:HLVX) IPO will take place April, 29 on the NASDAQ exchange under the ticker HLVX.
The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on October 26, 2022.
See also: Benzinga IPO Calendar
About HilleVax, Inc
HilleVax is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines.
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.